Vasodilator therapy of cardiac failure (second of two parts).
about
Phosphodiesterase III inhibitors for heart failureDopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptorsTheophylline disposition in Korean patients with congestive heart failure.Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosisCardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importanceDrug treatment of cardiac failure.Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapyVolume expansion and vasodilators in the treatment of idiopathic postural hypotension.Current concepts in vasodilator therapy for advanced or refractory congestive heart failure.Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.The effects of dopexamine on the cardiovascular system of the dogAnesthesiology-epitomes of progress: anesthetic management for patients with coronary artery disease.Vasodilators in heart failure.Pulse pressure, arterial compliance and wave reflection under differential vasoactive and mechanical loading.Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: a study in normal healthy volunteers.
P2860
Q24244978-3BA6BA54-5F38-49CF-92C6-E216114C6900Q24674107-01A1E702-6AB7-4FB0-AC63-91ABDB8F9F55Q34727998-B7E63C5F-6430-4584-99FA-4893C3F1DBF8Q34778812-C73928BB-5862-4926-B6D6-33E7FAE59F6CQ36360615-6BD7CA6A-8C2C-4426-8485-E035193CF500Q37432103-81F2B84D-4B8D-442C-8AF7-276C9729F0B8Q37834970-8E3E6B81-ECB8-492F-933E-65C41F634448Q38282980-5AC30C8D-F86D-48A4-8810-103EFC601132Q38576214-4CB085CD-FE9F-4D12-85BC-83C6E6717F5CQ40490772-9941ECB2-A932-4146-BE85-4417FF676509Q41300220-E949C8A8-40C8-437A-857C-CABA450E0663Q41787117-1A71BC70-324D-4D1B-A0A9-0B0289561BEFQ42288062-14F8401F-3957-42DA-B7D9-282392B1E840Q42343314-E67139DE-F65B-44D6-8C95-8EA8ECC4DB00Q42779535-D776DE59-1DAD-4923-A7F9-10B74B240B1BQ43229141-47C0EDF8-1614-4945-9177-C56F71A7D1FC
P2860
Vasodilator therapy of cardiac failure (second of two parts).
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Vasodilator therapy of cardiac failure (second of two parts).
@en
Vasodilator therapy of cardiac failure
@nl
type
label
Vasodilator therapy of cardiac failure (second of two parts).
@en
Vasodilator therapy of cardiac failure
@nl
prefLabel
Vasodilator therapy of cardiac failure (second of two parts).
@en
Vasodilator therapy of cardiac failure
@nl
P1476
Vasodilator therapy of cardiac failure (second of two parts).
@en
P2093
P304
P356
10.1056/NEJM197708042970506
P407
P577
1977-08-01T00:00:00Z